Healthcare provider profile · identity verified

Reena Kunreddy, M.D

Internal Medicine · MOLINE, IL · NPI 1205122496

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	684	187
Levothyroxine Sodium	Levothyroxine Sodium	432	106
Losartan Potassium	Losartan Potassium	378	98
Amlodipine Besylate	Amlodipine Besylate	370	91
Lisinopril	Lisinopril	326	85
Omeprazole	Omeprazole	323	92
Alprazolam	Alprazolam	236	53
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	228	43
Metformin Hcl	Metformin Hcl	224	63
Hydrochlorothiazide	Hydrochlorothiazide	215	55
Meloxicam	Meloxicam	212	52
Sertraline Hcl	Sertraline Hcl	212	39
Gabapentin	Gabapentin	202	60
Albuterol Sulfate Hfa	Albuterol Sulfate	190	68
Simvastatin	Simvastatin	186	46
Furosemide	Furosemide	169	43
Tramadol Hcl	Tramadol Hcl	163	44
Escitalopram Oxalate	Escitalopram Oxalate	152	30
Zolpidem Tartrate	Zolpidem Tartrate	142	30
Metoprolol Succinate	Metoprolol Succinate	141	35
Rosuvastatin Calcium	Rosuvastatin Calcium	139	44
Ozempic	Semaglutide	137	16
Carvedilol	Carvedilol	131	30
Potassium Chloride	Potassium Chloride	122	33
Trazodone Hcl	Trazodone Hcl	122	31
Mounjaro	Tirzepatide	121	16
Prednisone	Prednisone	115	89
Alendronate Sodium	Alendronate Sodium	112	37
Metformin Hcl Er	Metformin Hcl	111	29
Metoprolol Tartrate	Metoprolol Tartrate	109	25
Pantoprazole Sodium	Pantoprazole Sodium	106	28
Fluticasone Propionate	Fluticasone Propionate	98	26
Eliquis	Apixaban	89	19
Azithromycin	Azithromycin	87	74
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	86	17
Allopurinol	Allopurinol	83	20
Tamsulosin Hcl	Tamsulosin Hcl	83	22
Doxycycline Hyclate	Doxycycline Hyclate	82	69
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	81	24
Clopidogrel	Clopidogrel Bisulfate	78	20
Jardiance	Empagliflozin	78	16
Memantine Hcl	Memantine Hcl	76	18
Montelukast Sodium	Montelukast Sodium	75	17
Duloxetine Hcl	Duloxetine Hcl	71	13
Glipizide Er	Glipizide	71	23
Pravastatin Sodium	Pravastatin Sodium	70	19
Ropinirole Hcl	Ropinirole Hcl	66	14
Triamcinolone Acetonide	Triamcinolone Acetonide	60	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	17
Venlafaxine Hcl Er	Venlafaxine Hcl	58	13
Lorazepam	Lorazepam	57	16
Ezetimibe	Ezetimibe	56	17
Clonazepam	Clonazepam	52	11
Baclofen	Baclofen	51	suppressed
Glipizide	Glipizide	51	14
Methocarbamol	Methocarbamol	51	25
Bupropion Xl	Bupropion Hcl	50	14
Citalopram Hbr	Citalopram Hydrobromide	49	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	48	35
Chlorthalidone	Chlorthalidone	47	12
Ibandronate Sodium	Ibandronate Sodium	47	14
Lovastatin	Lovastatin	41	suppressed
Propranolol Hcl	Propranolol Hcl	41	suppressed
Mirtazapine	Mirtazapine	40	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	40	suppressed
Bupropion Hcl Sr	Bupropion Hcl	39	suppressed
Irbesartan	Irbesartan	39	12
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	38	11
Symbicort	Budesonide/Formoterol Fumarate	37	suppressed
Celecoxib	Celecoxib	35	suppressed
Glimepiride	Glimepiride	35	suppressed
Pregabalin	Pregabalin	35	11
Atenolol	Atenolol	34	suppressed
Nabumetone	Nabumetone	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Propranolol Hcl Er	Propranolol Hcl	34	suppressed
Famotidine	Famotidine	33	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	32	13
Nifedipine Er	Nifedipine	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Carbamazepine Er	Carbamazepine	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Nystatin	Nystatin	25	16
Valsartan	Valsartan	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Nebivolol Hcl	Nebivolol Hcl	23	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Temazepam	Temazepam	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Testosterone Cypionate	Testosterone Cypionate	21	suppressed
Cephalexin	Cephalexin	20	15
Donepezil Hcl	Donepezil Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Methylprednisolone	Methylprednisolone	19	17
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	15
Trulicity	Dulaglutide	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	14
Meclizine Hcl	Meclizine Hcl	17	11
Spironolactone	Spironolactone	17	suppressed
Topiramate	Topiramate	17	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Levofloxacin	Levofloxacin	16	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Dulera	Mometasone/Formoterol	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	13	suppressed
Linzess	Linaclotide	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Butrans	Buprenorphine	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Rybelsus	Semaglutide	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Naproxen	Naproxen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error